Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 15,322,536	$ 420,976
Adjustments to reconcile net income to net cash used in operating activities:
Change in fair value of warrant liabilities	(17,457,982)	(2,166,000)
Interest earned on marketable securities held in Trust Account	(1,272,744)	(15,440)
Transaction costs incurred in connection with IPO		520,319
Prepaid expenses	125,949	(271,762)
Accrued expenses	2,896,499	357,683
Net cash used in operating activities	(385,742)	(1,154,224)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(230,000,000)
Net cash used in investing activities		(230,000,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid		226,000,000
Proceeds from sale of Private Placement Warrants		6,000,000
Proceeds from promissory note – related party	304,980	60,910
Advances from related parties	2,500	870
Over payment of promissory note		25,000
Refund of over payment of promissory note		(155,410)
Payment of offering costs		(374,749)
Net cash provided by financing activities	307,480	231,556,621
Net Change in Cash and cash equivalents	(78,262)	402,397
Cash and cash equivalents – Beginning	91,407
Cash and cash equivalents – Ending	13,145	402,397
Non-cash investing and financing activities:
Remeasurement of Class A ordinary shares subject to redemption amount	1,272,745
Initial classification of public warrant liability		8,970,000
Initial classification of private warrant liability		4,740,000
Initial classification of Class A ordinary shares subject to possible redemption		230,015,440
Deferred underwriting fee payable		$ 8,650,000